Humanigen is not currently accepting enquiries regarding lenzilumab™ for emergency use.

Humanigen's Phase III study in COVID-19 is now enrolling. For more information, visit StopStorm.com

See also:

Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients (more information)

Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients (more information)

Follow Us

  • Twitter
  • LinkedIn
  • Facebook

©2021 Humanigen, Inc.  All rights reserved